Hossein Sadrzadeh1, Robert Hasserjian, Amir T Fathi. Show Affiliations » 1. Department of Hematology/Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Abstract
Entities: Disease
Mesh： See more » Abnormal KaryotypeAgedAntineoplastic Combined Chemotherapy Protocols/adverse effectsCladribine/administration & dosageCyclophosphamide/administration & dosageFatal OutcomeHumansLeukemia, Erythroblastic, Acute/etiologyLeukemia, Erythroblastic, Acute/geneticsLeukemia, Erythroblastic, Acute/pathologyLeukemia, Lymphocytic, Chronic, B-Cell/drug therapyLeukemia, Lymphocytic, Chronic, B-Cell/geneticsLeukemia, Lymphocytic, Chronic, B-Cell/pathologyMaleMyelodysplastic Syndromes/etiologyMyelodysplastic Syndromes/geneticsMyelodysplastic Syndromes/pathologyPrednisone/administration & dosageVidarabine/administration & dosageVidarabine/analogs & derivativesVincristine/administration & dosage
Substances： See more » CladribineVincristineCyclophosphamideVidarabinefludarabinePrednisone
Year: 2012 PMID： 22565525 DOI： 10.1002/ajh.23224
Source DB: PubMed Journal: Am J Hematol ISSN： 0361-8609 Impact factor: 10.047